Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Altech – Commences Selling Sodium Nickel Chloride Batteries September 30, 2025 Alice Queen: Exploring High-grade Epithermal Gold with Near-term... August 22, 2025 E-Power Resources Inc. Announces Flow-Through and Hard Dollar... June 12, 2025 Investment Protection Agreement with the Ecuador Government on... May 28, 2025 Editor’s Picks: Trump to Lift Minnesota Mining Ban,... June 14, 2025 Alvopetro Announces Production Results from Murucututu 183-D4 Well... August 26, 2025 Westport Announces Lock-Up Agreements in Support of the... May 1, 2025 Gold Price Hits New Record, Breaks US$4,500; Silver,... December 24, 2025 Crypto Market Recap: Strategy Eyes US$1 Billion Capital... June 7, 2025 Lode Gold Engages Strategic Advisors to Advance Development... June 25, 2025